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For many years toxemia has served
as a wastebasket for a variety of disease states characterized by an elevated arterial pressure, edema, and
albuminuria. Whereas this triad is consistent with the diagnosis of toxemia,
it is not diagnostic. Besides toxemia,
these abnormalities may be found in
pregnant patients with hypertensive
vascular disease, pyelonephritis, glomerulonephritis, or any combination
of these (fig. 1). Data derived from
studies performed on patients with
such a variety of disease entities have
obviously been confusing. It makes a
lot of difference, for example, whether
the subjects studied had chronic pyelonephritis or acute vasospastic toxemia.
During the past 13 years, our group
has attempted to cut the pie of elevated arterial pressure, albuminuria,
and edema into separate and distinct
diagnostic pieces. Ophthalmoscopic
examination and urinalysis have been
of great help in this regard (Finnerty,
1954, 1956 and 1965; Finnerty et al. ,
1960).
Diagnosis

The finding of normal fundi and albuminuria suggested pyelonephritis.
Clumps of cells in the urine and a positive colony count documented the diagnosis.
Figure 3 gives the diagnostic breakdown in 4,273 patients followed in our
toxemia clinic during the past 3 years.
It is interesting to note the frequency
of pyelonephritis and hypertensive vascular disease, and the relative rarity
of true toxemia. The recent biopsy
studies of Altchek (1961) would seem
to substantiate the finding that most
patients originally thought to have toxemia actually have some other disease.
The specific biopsy picture for toxemia
has for the first time significantly clarified this wastebasket of syndromes. It
would seem that toxemia is another
type of glomerulonephritis. Figure 4
shows the similarity between toxemia
and glomerulonephritis. Both diseases
are characterized by a greater rise in
the diastolic than the systolic pressure,
which causes a narrow pulse pressure.
The edema is particularly in the periorbital areas, hands and feet. Ophthalmoscopic examination reveals thread-

Toxemia was diagnosed when the
ophthalmoscopic examination revealed
spasm of the retinal arteries with no
retinopathy, and urinalysis revealed
only albuminuria (fig. 2). Hypertensive
vascular disease existed when the retinal arteries were either normal or
thickened and tortuous with AV nicking. When both signs of chronic vascular disease and acute vasospasm
were observed with or without albuminuria, toxemia was then superimposed on hypertensive vascular disease.

* Presented at the Thirty-sixth Annual
McGuire Lecture Series at the Medical
College of Virginia, October 8, 1964.
32

Fig.1.-Elevated blood pressure, albuminuria and edema are seen in toxemia
but also in several other conditions.
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DIFFERENTIAL DIAGNOSIS
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like arteries and generalized wetness of
the retina. Both diseases are characterized by albuminuria.
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Fig. 2-0phthalmoscopic examination and urinalysis in the differential diagnosis of
toxemia.

THE DIAGNOSIS IN 4 273 PATIENTS
1961 - 1963
PURE TOXEMIA ••••••••••••••••••••.••...••.•.•.•..• 167
TOXEMIA+ HYPERTENSIVE VASCULAR DISEASE ....... 42
TOXEMIA+ PYELONEPHRITIS ...................... . . 67
PYELONEPHRITIS •••••••.•.•....•...•......••....... 704
PYELONEPHRITIS +HYPERTENSIVE VASC . DISEASE ... 287
HYPERTENSIVE VASCULAR DISEASE .. . ... . ........... 804
GLOMERULONEPHR ITI S •••••.•.•.•..••.•.•. • .......•. 84
NON-RELATED MEDICAL DISEASE ..................... 214
(ANEMIA, HEART DISEASE, ETC.)
EDEMA WITHOUT DISEASE. ....... . ....... . .......... 387
ASYMPTOMATIC BACTERURIA ••...••.• • •.•. • . • .•.••.. 469
NO DISEASE •••.••••••..••••...... • .....••......•... 944
QUESTIONABLE DIAGNOSIS ••••.••.•••. • ...•••....... 104
TOT AL
T,273

Fig. 3-Diagnostic features in patients attending the toxemia clinic
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All the signs and symptoms of toxemia may be adequately explained by
abnormal sodium retention and generalized vasoconstriction (fig. 5). The
relationship between the two is unknown, but clinical observation attests
that sodium retention usually precedes
generalized vasoconstriction, and that
prompt therapy of sodium retention
usually prevents generalized vasoconstriction. The studies of Eisenberg
(1959) in patients with acute nephritis,
and Finnerty (1962) in patients with
toxemia, show that there is an increase
in plasma volume without an increase
in circulating red cell mass. Following
diuretic therapy the plasma volume returns to normal. This pattern of blood
volume expansion, therefore, contrasts
sharply with that in patients with congestive heart failure in whom there is
a commensurate increase in red cell
mass and plasma volume. These data
suggest that an abnormality of salt and
water metabolism is solely responsible
for the hypervolemia of acute nephritis and toxemia.
A decrease in the amount of blood
to a particular area due to increased
vasoconstriction explains the remainder of the abnormality. An increase in
cerebral vasoconstriction causes cerebral ischemia, leading to coma and
convulsions. It is interesting in this regard to emphasize that it is cerebral
ischemia, and not a rise in arterial
pressure, that is the important abnormality in inducing coma and convulsions. The exact same symptoms may
be caused by postural hypotension or
an attack of Stokes-Adams syncope.
Evidence of both sodium retention
and vasoconstriction, the two pathophysiologic abnormalities, can be visualized ophthalmoscopically. A wet,
glistening appearance of the entire
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TOXEMIA OF PREGNANCY

retina (retinal sheen) and a decrease in
the caliber of the retinal arteries characterize toxemia. The observation that
the generalized sheen of toxemia is
promptly decreased following diuretic
therapy strongly suggests that it represents retinal edema.
Increased constriction of the peripheral vessels seems to account for
the elevated arterial pressure. The increase in arterial pressure in toxemia
is not associated in a change in the
cardiac output. Finally, the increased
vasoconstriction in the renal circulation, particularly in the afferent vessels
as noted by Assali et al. (1953) accounts, in part at least, for the decrease in urinary output. The decrease
in urinary output is part of the toxemic
process and not necessarily a complication.
In summary, then, the toxemic process can be divided into two phases:
the sodium retention phase, and the
phase of sodium retention plus generalized vasoconstriction (fig. 6). The
sodium retention phase is characterized by an increase in plasma volume
which returns to normal following
therapy. Prompt therapy will frequently prevent the development of the
second phase.
Therapy

The availability of the thiazides has
completely changed the concept of the
treatment of toxemia. Prior to their
development, the primary aim of therapy of toxemia was directed toward
the control of arterial pressure and
albuminuria (manisfestations of generalized vasoconstriction). Reserpine,
hydralazine, and veratrum, therefore,
were used extensively in our clinic, as
well as in others. If the arterial pressure could not be lowered sufficiently,
additional antihypertensive agents were
added.
The primary aim of therapy of toxemia, at present, is prompt control of
sodium retention. The effectiveness of
the thiazides in immediately controlling abnormal sodium retention, and in
returning the plasma volume to normal, has frequently prevented the development of generalized vasoconstriction and thereby practically eliminated
the need of antihypertensive therapy
in these patients. When used alone at
the first sign of excessive weight gain,
34
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Fig. 5-Pathogenesis of toxemia

the thiazides frequently reverse the
toxemic process. Even more important
is the observation that they can be administered continuously without the
development of drug resistance, thus
preventing the development of vasoconstriction. For practical purposes,
the prevention of vasoconstriction is
equivalent to the preventing of toxemia. In our experience, these diuretic
agents have resulted in more than a
70 % reduction in the number of patients with toxemia during the past
two years.
If signs of vasoconstriction (retinal
arterial spasm and albuminuria or
either of them alone) are already present when the patient first presents herself, she probably should be hospitalized. It should be stressed that the
primary aim of therapy in the hospitalized patient is preparation of the
patient for delivery or Cesarean section. Whereas for the out-patient, sodium diuretics are the only agents
needed, in the hospitalized patient
these drugs serve only as background
agents. Vasodilating agents must now
also be administered.
We have recently had experience
with a nondiuretic benzothiadiazine
analogue whose structural formula is
very similar to chlorothiazide (fig. 7).
When administered by mouth it causes
only a small reduction in arterial pressure, and also causes sodium retention
and hyperglycemia. When administered by vein, however, it is a potent
vasodilating agent. The average effective dosage is 300 mg (1 ampule) given
rapidly, undiluted. To date, 69 patients
with severe pre-eclampsia and 2 with
eclampsia have received diazoxide
with excellent results. The typical ef-
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Fig. 6-Two Main phases of toxemia
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feet of 300 mg of diazoxide can be
seen in figure 8. A 35% average reduction in mean arterial pressure occurred
during the first 2 minutes. During the
next 3 to 5 minutes, the arterial pressure increased gradually, leveling off
at 19% average reduction as compared with the control. No signs of
postural hypotension, cerebral ischemia, or collapse were noted.
The fall in arterial pressure with
diazoxide is consistently associated
with an increase in cardiac output, and
a decrease in total peripheral resistance. From the cardiac and cerebral
hemodynamic standpoint, diazoxide
resembles hydralazine since both
agents cause an increase in cardiac
output, heart rate, and cerebral blood
flow. Actual cerebral blood flow determinations have not been performed
in this laboratory, but the lack of
signs of cerebral ischemia accompanying the reduction in arterial pressure,
and the increase in cardiac output,
strongly indicate that there is at least
maintenance of the cerebral blood
flow, even at the point of the greatest
magnitude of hypotensive action.
Our experience thus far would indicate that diazoxide represented a real
advance in the therapy of acute vasospastic hypertension.

Prevention
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Experience has shown that it is
easier to prevent toxemia than to treat
it. Although the thiazide diuretics seem
to be the ideal agents for the treatment
of the sodium retention phase of toxemia, their greatest asset is that they
can be given continuously without the
problem of drug resistance. I feel,
therefore, that the thiazides should
not only be given at the first sign of
sodium retention, but should be instituted from the tenth week of pregnacy in patients who are candidates for
toxemia, e.g., patients with chronic hypertensive vascular disease, patients
with chronic renal disease, and probably all primagravida patients. The data
on more than 6,000 patients treated
with thiazides has shown that the continued use of these drugs following
the tenth week of pregnancy apparently is not harmful to the fetus.
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